Quanterix Q2 revenue drops 29% to $24.5M; net loss widens to $30M; guides FY25 revenue $130-135M

Quanterix Corp

2025-Q2 EPS reported -$1.30 vs consensus -$0.37 ▼ miss (-254.0%)

GAAP net loss $30.0M vs $7.4M in Q2 2024; GAAP gross margin 46.2% vs 64.7%.
Revenue $24.5M down 29% YoY; Alzheimer's Diagnostics revenue more than tripled.
Closed Akoya acquisition in early July; $64M of $85M cost reduction target achieved.
FY 2025 revenue guidance $130-135M (incl. ~2 quarters Akoya); pro forma $165-170M.
Expects cash flow breakeven in 2026; exiting 2025 with ~$120M cash.

item 2.02item 5.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.